Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-09-28

AUTHORS

Nitzan Avisar, Yael Heller, Clara Weil, Aviva Ben-Baruch, Shani Potesman-Yona, Ran Oren, Gabriel Chodick, Varda Shalev, Nachman Ash

ABSTRACT

BackgroundIn January 2015, the first interferon-free direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection was approved for inclusion in Israel’s national basket of health services. During 2015, HCV genotype 1 patients with advanced liver fibrosis (stage F3-F4) were eligible for treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir (OMB/PTV/r + DSV) provided through the four national health plans. As all health plans committed to identifying eligible patients nationwide, risk-sharing agreements created an additional incentive to develop an innovative model for rapid treatment delivery.AimThis article aims to describe the development and implementation of a multi-disciplinary patient-centered model for the expedited provision of costly therapies in a community setting, based on experience delivering new HCV therapy in 2015.MethodsWe present the case of the Central District in Maccabi Healthcare Services (MHS), one of five districts in a 2-million-member healthcare provider. We describe the dimensions of the model and its implementation, including the composition and responsibilities of the multi-disciplinary team, screening for patient eligibility, provision of care, and barriers and facilitators identified at each stage.ResultsThe experience of the MHS Central District indicates that good communication between all stakeholders was the key driver of successful implementation of the model. Overall, monthly treatment uptake increased following the intervention and by the end of 2015 a total of 99 patients were treated with OMB/PTV/r + DSV in this district. Early data indicate high effectiveness in this population and evaluation in ongoing.ConclusionsThis multi-disciplinary patient-centered model enabled rapid integration of screening and disease staging to identify and treat eligible HCV patients in the MHS central district. The model forms the basis of the 2017 project to deliver DAAs according to broader health basket criteria and may be adapted for the provision of other innovative health technologies in different healthcare settings. More... »

PAGES

46

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13584-017-0172-1

DOI

http://dx.doi.org/10.1186/s13584-017-0172-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091439744

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28954630


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Services Accessibility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Israel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient-Centered Care", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Avisar", 
        "givenName": "Nitzan", 
        "id": "sg:person.011331350033.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331350033.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heller", 
        "givenName": "Yael", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weil", 
        "givenName": "Clara", 
        "id": "sg:person.0671526347.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671526347.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ben-Baruch", 
        "givenName": "Aviva", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Potesman-Yona", 
        "givenName": "Shani", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology and Liver Diseases, Hadassah Ein Karem Hospital, Jerusalem, Israel", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Gastroenterology and Liver Diseases, Hadassah Ein Karem Hospital, Jerusalem, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oren", 
        "givenName": "Ran", 
        "id": "sg:person.0657625535.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657625535.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.12136.37", 
          "name": [
            "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel", 
            "Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chodick", 
        "givenName": "Gabriel", 
        "id": "sg:person.01046761047.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046761047.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.12136.37", 
          "name": [
            "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel", 
            "Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shalev", 
        "givenName": "Varda", 
        "id": "sg:person.0665536233.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665536233.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel", 
          "id": "http://www.grid.ac/institutes/grid.425380.8", 
          "name": [
            "Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ash", 
        "givenName": "Nachman", 
        "id": "sg:person.01205514201.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205514201.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2334-14-74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004852434", 
          "https://doi.org/10.1186/1471-2334-14-74"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt0114-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005277907", 
          "https://doi.org/10.1038/nbt0114-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10900-007-9083-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031090861", 
          "https://doi.org/10.1007/s10900-007-9083-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13584-016-0088-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052146115", 
          "https://doi.org/10.1186/s13584-016-0088-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-09-28", 
    "datePublishedReg": "2017-09-28", 
    "description": "BackgroundIn January 2015, the first interferon-free direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection was approved for inclusion in Israel\u2019s national basket of health services. During 2015, HCV genotype 1 patients with advanced liver fibrosis (stage F3-F4) were eligible for treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir (OMB/PTV/r\u00a0+\u00a0DSV) provided through the four national health plans. As all health plans committed to identifying eligible patients nationwide, risk-sharing agreements created an additional incentive to develop an innovative model for rapid treatment delivery.AimThis article aims to describe the development and implementation of a multi-disciplinary patient-centered model for the expedited provision of costly therapies in a community setting, based on experience delivering new HCV therapy in 2015.MethodsWe present the case of the Central District in Maccabi Healthcare Services (MHS), one of five districts in a 2-million-member healthcare provider. We describe the dimensions of the model and its implementation, including the composition and responsibilities of the multi-disciplinary team, screening for patient eligibility, provision of care, and barriers and facilitators identified at each stage.ResultsThe experience of the MHS Central District indicates that good communication between all stakeholders was the key driver of successful implementation of the model. Overall, monthly treatment uptake increased following the intervention and by the end of 2015 a total of 99 patients were treated with OMB/PTV/r\u00a0+\u00a0DSV in this district. Early data indicate high effectiveness in this population and evaluation in ongoing.ConclusionsThis multi-disciplinary patient-centered model enabled rapid integration of screening and disease staging to identify and treat eligible HCV patients in the MHS central district. The model forms the basis of the 2017 project to deliver DAAs according to broader health basket criteria and may be adapted for the provision of other innovative health technologies in different healthcare settings.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13584-017-0172-1", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046900", 
        "issn": [
          "2045-4015"
        ], 
        "name": "Israel Journal of Health Policy Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "patient-centered model", 
      "Maccabi Healthcare Services", 
      "costly therapies", 
      "chronic hepatitis C virus (HCV) infection", 
      "ombitasvir/paritaprevir/ritonavir", 
      "hepatitis C virus infection", 
      "HCV genotype 1 patients", 
      "community settings", 
      "health plans", 
      "paritaprevir/ritonavir", 
      "new HCV therapies", 
      "acting antiviral (DAA) therapy", 
      "C virus infection", 
      "genotype 1 patients", 
      "advanced liver fibrosis", 
      "different healthcare settings", 
      "national health plan", 
      "provision of care", 
      "national basket", 
      "eligible patients", 
      "HCV patients", 
      "HCV therapy", 
      "hepatitis C", 
      "antiviral therapy", 
      "treatment uptake", 
      "patient eligibility", 
      "liver fibrosis", 
      "new medications", 
      "multi-disciplinary team", 
      "virus infection", 
      "healthcare providers", 
      "health services", 
      "patients", 
      "therapy", 
      "healthcare settings", 
      "treatment delivery", 
      "innovative health technologies", 
      "healthcare services", 
      "health technologies", 
      "rapid treatment delivery", 
      "risk-sharing agreements", 
      "good communication", 
      "setting", 
      "dasabuvir", 
      "medications", 
      "earlier data", 
      "ritonavir", 
      "fibrosis", 
      "infection", 
      "disease", 
      "care", 
      "eligibility", 
      "intervention", 
      "treatment", 
      "total", 
      "DAA", 
      "cases", 
      "screening", 
      "innovative model", 
      "delivery", 
      "high effectiveness", 
      "providers", 
      "experience", 
      "central district", 
      "population", 
      "provision", 
      "facilitators", 
      "uptake", 
      "district", 
      "DSV", 
      "criteria", 
      "evaluation", 
      "team", 
      "services", 
      "plan", 
      "successful implementation", 
      "barriers", 
      "stage", 
      "inclusion", 
      "data", 
      "key drivers", 
      "development", 
      "model", 
      "effectiveness", 
      "rapid integration", 
      "end", 
      "present", 
      "basket", 
      "additional incentives", 
      "implementation", 
      "basis", 
      "article", 
      "responsibility", 
      "communication", 
      "stakeholders", 
      "drivers", 
      "composition", 
      "project", 
      "agreement", 
      "integration", 
      "dimensions", 
      "incentives", 
      "technology"
    ], 
    "name": "Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C", 
    "pagination": "46", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091439744"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13584-017-0172-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28954630"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13584-017-0172-1", 
      "https://app.dimensions.ai/details/publication/pub.1091439744"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_733.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13584-017-0172-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13584-017-0172-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13584-017-0172-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13584-017-0172-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13584-017-0172-1'


 

This table displays all metadata directly associated to this object as RDF triples.

273 TRIPLES      21 PREDICATES      139 URIs      127 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13584-017-0172-1 schema:about N1b3ec1a3d05a4fa1b738ab3fedfab54d
2 N1b6d0817897242cfbe5c1d1c9f73a36d
3 N21a70771384544bfa984733f9863cb9b
4 N3d355dfa4c664f3aae15304f303eeec0
5 N5803263738c24b63ba3f0cade738c4f1
6 N6161529a488048c18ca7343df73ced87
7 N76210bff4f8949088177f580e650a371
8 Ne5247d40dace41729b87c0e0515f0f63
9 anzsrc-for:11
10 anzsrc-for:1117
11 schema:author Nf0beb4c736594abfa7229673ad725bd4
12 schema:citation sg:pub.10.1007/s10900-007-9083-3
13 sg:pub.10.1038/nbt0114-3
14 sg:pub.10.1186/1471-2334-14-74
15 sg:pub.10.1186/s13584-016-0088-1
16 schema:datePublished 2017-09-28
17 schema:datePublishedReg 2017-09-28
18 schema:description BackgroundIn January 2015, the first interferon-free direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection was approved for inclusion in Israel’s national basket of health services. During 2015, HCV genotype 1 patients with advanced liver fibrosis (stage F3-F4) were eligible for treatment with ombitasvir/paritaprevir/ritonavir and dasabuvir (OMB/PTV/r + DSV) provided through the four national health plans. As all health plans committed to identifying eligible patients nationwide, risk-sharing agreements created an additional incentive to develop an innovative model for rapid treatment delivery.AimThis article aims to describe the development and implementation of a multi-disciplinary patient-centered model for the expedited provision of costly therapies in a community setting, based on experience delivering new HCV therapy in 2015.MethodsWe present the case of the Central District in Maccabi Healthcare Services (MHS), one of five districts in a 2-million-member healthcare provider. We describe the dimensions of the model and its implementation, including the composition and responsibilities of the multi-disciplinary team, screening for patient eligibility, provision of care, and barriers and facilitators identified at each stage.ResultsThe experience of the MHS Central District indicates that good communication between all stakeholders was the key driver of successful implementation of the model. Overall, monthly treatment uptake increased following the intervention and by the end of 2015 a total of 99 patients were treated with OMB/PTV/r + DSV in this district. Early data indicate high effectiveness in this population and evaluation in ongoing.ConclusionsThis multi-disciplinary patient-centered model enabled rapid integration of screening and disease staging to identify and treat eligible HCV patients in the MHS central district. The model forms the basis of the 2017 project to deliver DAAs according to broader health basket criteria and may be adapted for the provision of other innovative health technologies in different healthcare settings.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf Nb4c11a7d877a49c3a64821ae0b312fc2
22 Ne46ddf3a443f4ee3ae4d0bde17ac2976
23 sg:journal.1046900
24 schema:keywords C virus infection
25 DAA
26 DSV
27 HCV genotype 1 patients
28 HCV patients
29 HCV therapy
30 Maccabi Healthcare Services
31 acting antiviral (DAA) therapy
32 additional incentives
33 advanced liver fibrosis
34 agreement
35 antiviral therapy
36 article
37 barriers
38 basis
39 basket
40 care
41 cases
42 central district
43 chronic hepatitis C virus (HCV) infection
44 communication
45 community settings
46 composition
47 costly therapies
48 criteria
49 dasabuvir
50 data
51 delivery
52 development
53 different healthcare settings
54 dimensions
55 disease
56 district
57 drivers
58 earlier data
59 effectiveness
60 eligibility
61 eligible patients
62 end
63 evaluation
64 experience
65 facilitators
66 fibrosis
67 genotype 1 patients
68 good communication
69 health plans
70 health services
71 health technologies
72 healthcare providers
73 healthcare services
74 healthcare settings
75 hepatitis C
76 hepatitis C virus infection
77 high effectiveness
78 implementation
79 incentives
80 inclusion
81 infection
82 innovative health technologies
83 innovative model
84 integration
85 intervention
86 key drivers
87 liver fibrosis
88 medications
89 model
90 multi-disciplinary team
91 national basket
92 national health plan
93 new HCV therapies
94 new medications
95 ombitasvir/paritaprevir/ritonavir
96 paritaprevir/ritonavir
97 patient eligibility
98 patient-centered model
99 patients
100 plan
101 population
102 present
103 project
104 providers
105 provision
106 provision of care
107 rapid integration
108 rapid treatment delivery
109 responsibility
110 risk-sharing agreements
111 ritonavir
112 screening
113 services
114 setting
115 stage
116 stakeholders
117 successful implementation
118 team
119 technology
120 therapy
121 total
122 treatment
123 treatment delivery
124 treatment uptake
125 uptake
126 virus infection
127 schema:name Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C
128 schema:pagination 46
129 schema:productId N7924d76655c04199b57fae23ab1f64e7
130 N97c7882f5e694edf9253d51f1ecce7f1
131 Nc7fdb4aac16d4cecbbdaba1a6f3bfd89
132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091439744
133 https://doi.org/10.1186/s13584-017-0172-1
134 schema:sdDatePublished 2022-11-24T21:01
135 schema:sdLicense https://scigraph.springernature.com/explorer/license/
136 schema:sdPublisher N64d7af72bc2c43baaeede85b172061d8
137 schema:url https://doi.org/10.1186/s13584-017-0172-1
138 sgo:license sg:explorer/license/
139 sgo:sdDataset articles
140 rdf:type schema:ScholarlyArticle
141 N0f60442d3297496ca653a2ef73c537e8 schema:affiliation grid-institutes:grid.425380.8
142 schema:familyName Ben-Baruch
143 schema:givenName Aviva
144 rdf:type schema:Person
145 N1b3ec1a3d05a4fa1b738ab3fedfab54d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Drug Approval
147 rdf:type schema:DefinedTerm
148 N1b6d0817897242cfbe5c1d1c9f73a36d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antiviral Agents
150 rdf:type schema:DefinedTerm
151 N21a70771384544bfa984733f9863cb9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Health Services Accessibility
153 rdf:type schema:DefinedTerm
154 N27d41b1f50c440dc9468b70ed19ea012 schema:affiliation grid-institutes:grid.425380.8
155 schema:familyName Heller
156 schema:givenName Yael
157 rdf:type schema:Person
158 N36dc255509794098aa96953ff4132993 rdf:first N27d41b1f50c440dc9468b70ed19ea012
159 rdf:rest Nffb446b19708432aa4052ed919389762
160 N387c2a0411ad482985f630caaa21fef8 schema:affiliation grid-institutes:grid.425380.8
161 schema:familyName Potesman-Yona
162 schema:givenName Shani
163 rdf:type schema:Person
164 N3d355dfa4c664f3aae15304f303eeec0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Hepatitis C, Chronic
166 rdf:type schema:DefinedTerm
167 N4e7cc711382b4bac8d3b81bc6c7c9b2f rdf:first N387c2a0411ad482985f630caaa21fef8
168 rdf:rest Ndde2c95278864ea399b603eb7e647ac4
169 N5803263738c24b63ba3f0cade738c4f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Patient-Centered Care
171 rdf:type schema:DefinedTerm
172 N6161529a488048c18ca7343df73ced87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Israel
174 rdf:type schema:DefinedTerm
175 N64d7af72bc2c43baaeede85b172061d8 schema:name Springer Nature - SN SciGraph project
176 rdf:type schema:Organization
177 N76210bff4f8949088177f580e650a371 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Hepatitis C
179 rdf:type schema:DefinedTerm
180 N7924d76655c04199b57fae23ab1f64e7 schema:name doi
181 schema:value 10.1186/s13584-017-0172-1
182 rdf:type schema:PropertyValue
183 N97c7882f5e694edf9253d51f1ecce7f1 schema:name pubmed_id
184 schema:value 28954630
185 rdf:type schema:PropertyValue
186 Nb0e7470691c047bdb7f5392ae2838d23 rdf:first sg:person.01046761047.26
187 rdf:rest Nfe9b0116f8724aa2a7243e8fedb2861c
188 Nb4c11a7d877a49c3a64821ae0b312fc2 schema:issueNumber 1
189 rdf:type schema:PublicationIssue
190 Nbe2f2a97c49a4e9d906048bddd43cff4 rdf:first sg:person.01205514201.07
191 rdf:rest rdf:nil
192 Nc7fdb4aac16d4cecbbdaba1a6f3bfd89 schema:name dimensions_id
193 schema:value pub.1091439744
194 rdf:type schema:PropertyValue
195 Nd5784fe4bad2400caa05e08f23d29af8 rdf:first N0f60442d3297496ca653a2ef73c537e8
196 rdf:rest N4e7cc711382b4bac8d3b81bc6c7c9b2f
197 Ndde2c95278864ea399b603eb7e647ac4 rdf:first sg:person.0657625535.66
198 rdf:rest Nb0e7470691c047bdb7f5392ae2838d23
199 Ne46ddf3a443f4ee3ae4d0bde17ac2976 schema:volumeNumber 6
200 rdf:type schema:PublicationVolume
201 Ne5247d40dace41729b87c0e0515f0f63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Humans
203 rdf:type schema:DefinedTerm
204 Nf0beb4c736594abfa7229673ad725bd4 rdf:first sg:person.011331350033.57
205 rdf:rest N36dc255509794098aa96953ff4132993
206 Nfe9b0116f8724aa2a7243e8fedb2861c rdf:first sg:person.0665536233.33
207 rdf:rest Nbe2f2a97c49a4e9d906048bddd43cff4
208 Nffb446b19708432aa4052ed919389762 rdf:first sg:person.0671526347.72
209 rdf:rest Nd5784fe4bad2400caa05e08f23d29af8
210 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
211 schema:name Medical and Health Sciences
212 rdf:type schema:DefinedTerm
213 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
214 schema:name Public Health and Health Services
215 rdf:type schema:DefinedTerm
216 sg:journal.1046900 schema:issn 2045-4015
217 schema:name Israel Journal of Health Policy Research
218 schema:publisher Springer Nature
219 rdf:type schema:Periodical
220 sg:person.01046761047.26 schema:affiliation grid-institutes:grid.12136.37
221 schema:familyName Chodick
222 schema:givenName Gabriel
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046761047.26
224 rdf:type schema:Person
225 sg:person.011331350033.57 schema:affiliation grid-institutes:grid.425380.8
226 schema:familyName Avisar
227 schema:givenName Nitzan
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331350033.57
229 rdf:type schema:Person
230 sg:person.01205514201.07 schema:affiliation grid-institutes:grid.425380.8
231 schema:familyName Ash
232 schema:givenName Nachman
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205514201.07
234 rdf:type schema:Person
235 sg:person.0657625535.66 schema:affiliation grid-institutes:None
236 schema:familyName Oren
237 schema:givenName Ran
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657625535.66
239 rdf:type schema:Person
240 sg:person.0665536233.33 schema:affiliation grid-institutes:grid.12136.37
241 schema:familyName Shalev
242 schema:givenName Varda
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665536233.33
244 rdf:type schema:Person
245 sg:person.0671526347.72 schema:affiliation grid-institutes:grid.425380.8
246 schema:familyName Weil
247 schema:givenName Clara
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671526347.72
249 rdf:type schema:Person
250 sg:pub.10.1007/s10900-007-9083-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031090861
251 https://doi.org/10.1007/s10900-007-9083-3
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/nbt0114-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005277907
254 https://doi.org/10.1038/nbt0114-3
255 rdf:type schema:CreativeWork
256 sg:pub.10.1186/1471-2334-14-74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004852434
257 https://doi.org/10.1186/1471-2334-14-74
258 rdf:type schema:CreativeWork
259 sg:pub.10.1186/s13584-016-0088-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052146115
260 https://doi.org/10.1186/s13584-016-0088-1
261 rdf:type schema:CreativeWork
262 grid-institutes:None schema:alternateName Institute of Gastroenterology and Liver Diseases, Hadassah Ein Karem Hospital, Jerusalem, Israel
263 schema:name Institute of Gastroenterology and Liver Diseases, Hadassah Ein Karem Hospital, Jerusalem, Israel
264 rdf:type schema:Organization
265 grid-institutes:grid.12136.37 schema:alternateName Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
266 schema:name Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel
267 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
268 rdf:type schema:Organization
269 grid-institutes:grid.425380.8 schema:alternateName Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel
270 Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel
271 schema:name Central District, Maccabi Healthcare Services, Yoni Netanyahu 5/31, Petach Tikva, Israel
272 Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel
273 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...